Shiraz Ladiwala
Patrimonio netto: 869 516 $ in data 31/05/2026
Patrimonio netto: 869 516 $ in data 31/05/2026
Shiraz S.
Ladiwala is currently Lead Independent Director at Mesa Laboratories, Inc. since 2022.
Former positions include Non-Executive Director at Patheon NV and Senior VP-Business Transformation Projects at Thermo Fisher Scientific, Inc. from 2020 to 2021.
Education includes an MBA from the University of Michigan and Stephen M.
Ross School of Business, and an undergraduate degree from the University of Mumbai.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/03/2026 | 8.523 ( 0,15% ) | 869 516 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MESA LABORATORIES, INC. | Direttore/Membro del Consiglio | 28/10/2021 |
| Società | Posizione | Fine |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 31/03/2021 |
| PATHEON N.V. | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Mesa Laboratories, Inc.
Mesa Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures computer-based electronic measurement instruments | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale